Also Wednesday, Takeda Pharmaceuticals announced that it would add the boxed warning requested by the FDA to prescription labels for Actos (pioglitazone).

• 同样也在星期三，武田制药公司宣布FDA要求的黑框警告会被添加到艾可拓（吡咯列酮）的处方标签上。